Cancer education for every nurse.

Nurse Oncology Education Program - Continuing Education for Nurses
New CE: Latest Targeted Therapies for Breast Cancer


NOEP's partner, inPractice Oncology Nursing, has introduced a Targeted Therapies continuing nursing education offering on the new first-in-class CDK inhibitor.  


Palbociclib is the newest targeted therapy for postmenopausal women with estrogen receptor-positive, HER2-negative advanced breast cancer. inPractice features critical nursing considerations in a brand new update from author Gail Wilkes, RNC, ANP-BC, MS, that covers:

  • Proper administration
  • Common side effects
  • Key nursing measures
To access this and other courses, register for your free 30-day trial subscription using access code NOEP4.


Editors-in-Chief: Rebecca Hawkins, MSN, ANP, AOCN, ACHPN and Dawn Camp Sorrell, MSN, FNP, AOCN

Brought to you by: Clinical Care Options  

USF Health is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Cancer Education for Every Nurse

In the U.S., cancer is the second-leading cause of death. Cancers that can be detected earlier by screening account for about half of all new cancer cases (American Cancer Society, 2014).

NOEP provides evidence-based continuing education to nurses on cancer prevention, detection, treatment, and survivorship. Our goal is to educate all nurses to create changes in nursing practice.

We partner with expert nurse clinicians and faculty from leading academic institutions to develop cutting edge programs, and conduct post-education evaluation and outcome measurement follow up to ensure those programs are effective. 

NOEP is a nonprofit project of the Texas Nurses Association/Foundation.